Position in LLY
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$7,300,929
+$5,781,471 QoQ
Shares Held
6,087
+268.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.92%
of 13F equity value
Holder Rank
#1,440
of 4,605 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 2%
Shared 0%
None 98%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Elyxium Wealth, LLC holds $29,523,474 across 8 Drug Manufacturers - General names. LLY ranks #2 (24.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
48,286 | $12,150,687 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
6,087 | $7,300,929 | |
| 3 | AMGN |
Amgen Inc
|
14,252 | $5,160,932 | |
| 4 | JNJ |
Johnson & Johnson
|
10,749 | $2,729,921 | |
| 5 | MRK |
Merck & Co., Inc.
|
7,919 | $1,017,591 | |
| 6 | PFE |
Pfizer Inc
|
20,580 | $495,565 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
3,502 | $442,441 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
3,912 | $225,408 |
All Filings in LLY
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,300,929 | 6,087 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $1,519,458 | 1,652 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $1,633,512 | 1,520 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $1,140,685 | 1,495 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $1,428,096 | 1,832 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $1,412,304 | 1,710 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $411,476 | 533 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,138,431 | 1,285 | Shares | Other | 2024-11-12 | |
| No filing history on record for this holder in this stock. | ||||||